Publications

A selection of group B strep publications authored or coauthored by CDC (2002—present)

MMWR Articles

• Notes from the field: Late-onset infant group B Streptococcus infection associated with maternal consumption of capsules containing dehydrated placenta — Oregon, 2016. MMWR Morb Mortal Wkly Rep. 2017;66(25):677–8.
• Prevention of perinatal group B streptococcal disease: Revised guidelines from CDC, 2010.
  MMWR Morb Mortal Wkly Rep. 2010;59(RR-10):1–32.
• Trends in perinatal group B streptococcal disease — United States, 2000–2006.
  MMWR Morb Mortal Wkly Rep. 2009;58(5):109–12.
• Perinatal group B streptococcal disease after universal screening recommendations — United States, 2003–2005.
  MMWR Morb Mortal Wkly Rep. 2007;56(28):701–5.
• Disparities in universal prenatal screening for group B Streptococcus — North Carolina, 2002–2003.
  MMWR Morb Mortal Wkly Rep. 2005;54(28):700–3.
• Diminishing racial disparities in early-onset neonatal group B streptococcal disease — United States, 2000–2003.
  MMWR Morb Mortal Wkly Rep. 2004;53(23):502–5.
• Prevention of perinatal group B streptococcal disease: Revised guidelines from CDC.
  MMWR. 2002;51(RR-11):1–22.

Prevention Strategies

• Kim SY, Nguyen C, Russell LB, Tomczyk S, Abdul-Hakeem F, Schrag SJ, et al. Cost-effectiveness of a potential group B streptococcal vaccine for pregnant women in the United States. Vaccine. 2017;35(45):6238–47.
• Kobayashi M, Schrag SJ, Alderson MR, Madhi SA, Baker CJ, Meulen AS, et al. WHO consultation on group B Streptococcus vaccine development: Report from a meeting held on 27–28 April 2016. Vaccine. 2016. [Epub ahead of print]
• Kobayashi M, Vekemans J, Baker CJ, Ratner AJ, Le Doare K, Schrag SJ. Group B Streptococcus vaccine development: Present status and future considerations, with emphasis on perspectives for low and middle income countries. F1000 Research. 2016;5:2355.
• Edwards RK, Tang Y, Raglan GB, Szychowski JM, Schulkin J, Schrag SJ. Survey of American obstetricians regarding group B Streptococcus: Opinions and practice patterns. Am J Obstet Gynecol. 2015;213(2):229.e1–7.
• Fairlie T, Zell ER, Schrag SJ. Effectiveness of intrapartum antibiotic prophylaxis for prevention of early-onset group B streptococcal disease. Obstet Gynecol. 2013;121(3):1–9.
• Koumans EH, Rosen J, Van Dyke MK, et al. Prevention of mother-to-child transmission of infections during pregnancy: implementation of recommended interventions, United States, 2003–2004. Am J Obstet Gynecol. 2012;206(2):158.e1–158.e11.
• Van Dyke MK, Phares CR, Lynfield R, et al. Evaluation of universal antenatal screening for group B Streptococcus. N Eng J Med. 2009;360(25):2626–36.
• Schrag SJ, Zell ER, Lynfield R, et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Eng J Med. 2002;347(4):233–9.

Neonatal Sepsis Trends

• Francois Watkins LK, McGee L, Schrag SJ, Beall B, Jain JH, Pondo T, et al. Epidemiology of invasive group B streptococcal infections among nonpregnant adults in the United States, 2008–2016. JAMA Intern Med. 2019;179(4):479–88.
• Nanduri SA, Petit S, Smelser C, Apostol M, Alden NB, Harrison LH, et al. Epidemiology of invasive early-onset and late-onset group B streptococcal disease in the United States, 2006 to 2015: Multistate laboratory and population-based surveillance. JAMA Pediatrics. 2019;173(3):224–33.
• Sigaúque B, Kobayashi M, Vubil D, Nhacolo A, Chaúque A, Moaine B, Massora S, et al. Invasive bacterial disease trends and characterization of group B streptococcal isolates among young infants in southern Mozambique, 2001-2015. PLoS One. 2018;13(1):e0191193.
• Lukacs SL, Schrag SJ. Clinical sepsis among neonates and young infants – United States, 1988–2006. J Pediatrics. 2012;161(3):573.
• Weston EJ, Pondo T, Lewis MM, et al. The burden of invasive early-onset neonatal sepsis in the United States, 2005–2008. Pediatr Infect Dis J. 2011;30(11):937–41.
• Deutscher M, Lewis M, Zell ER, et al. Incidence and severity of invasive Streptococcus pneumoniae, group A Streptococcus, and group B Streptococcus infections among pregnant and postpartum women. Clin Infect Dis. 2011;53(2):114–23.
• Stoll BJ, Hansen NI, Sánchez PI, et al. Early onset neonatal sepsis: the burden of group B streptococcal and coli disease continues. Pediatrics. 2011;127(5):817–26.
• Jordan HT, Farley MM, Craig A, et al. Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis. Pediatr Infect Dis J. 2008;27(12):1057–64.
• Phares CR, Lynfield R, Farley MM, et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999–2005. JAMA. 2008;299(17):2056–65.

 Top of Page

Neonatal Sepsis Risk Factors

• Schrag SJ, Hadler JL, Arnold KE, et al. Risk factors for invasive, early-onset Escherichia coli infections in the era of widespread intrapartum antibiotic use. Pediatrics. 2006;118(2):570–6.

Resistance Articles

• Hawkins PA, Law CS, Metcalf BJ, Cochua S, Jackson DM, Westblade LF, et al. Cross-resistance to lincosamides, streptogramins A and pleuromutilins in Streptococcus agalactiae isolates from the USA. J Antimicrob Chemother. 2017;72(7):1886–92.
• Metcalf BJ, Chochua S, Gertz RE Jr, Hawkins PA, Ricaldi J, Li Z, et al. Short-read whole genome sequencing for determination of antimicrobial resistance mechanisms and capsular serotypes of current invasive Streptococcus agalactiae recovered in the USA. Clin Microbiol Infect. 2017;23(8):574.e7–14.
• Seki T, Kimura K, Reid ME, et al. High isolation rate of MDR group B streptococci with reduced penicillin susceptibility in Japan. J Antimicrob Chemother. 2015;70(10):2725–8.
• Srinivasan V, Metcalf BJ, Knipe KM, Ouattara M, McGee L, Shewmaker PL, et al. vanG element insertions within a conserved chromosomal site conferring vancomycin resistance to Streptococcus agalactiae and Streptococcus anginosus. MBio. 2014;5(4):e01386–14.
• Park C, Nichols M, Schrag S. Two cases of invasive vancomycin-resistant group B Streptococcus infection. N Eng J Med. 2014;370:885–6.
• Castor ML, Whitney CG, Como-Sabetti K, et al. Antibiotic resistance patterns in invasive group B streptococcal isolates. Infect Dis Obstet Gynecol. 2008;2008:727505.

Review Articles

• Bianchi-Jassir F, Seale AC, Kohli-Lynch M, Lawn JE, Baker CJ, Bertlett L, et al. Preterm birth associated with group B Streptococcus maternal colonization worldwide: Systematic review and meta-analyses. Clin Infect Dis. 2017;65(2):S133–42.
• Hall J, Adams NH, Bartlet L, Seale AC, Lamagni T, Bianchi-Jassir F, et al. Maternal disease with group B Streptococcus and serotype distribution worldwide: System review and meta-analyses. Clin Infect Dis. 2017;65(2):S112–24.
• Kohli-Lynch M, Russell N, Seale AC, Dangor Z, Tann CJ, Baker CJ, et al. Neurodevelopmental impairment in children after group B Streptococcus disease worldwide: Systematic review and meta-analyses. Clin Infect Dis. 2017;65(2):S190–9.
• Lawn JE, Bianchi-Jassi F, Russell N, Kohli-Lynch M, Tann CJ, Hall J, et al. Group B streptococcal disease worldwide for pregnant women, stillbirths and children: Why, what and how to undertake estimates? Clin Infect Dis. 2017;65(2):S89–99.
• Le Doare K, O’Driscoll M, Turner K, Seedat F, Russell N, Seale AC, et al. Intrapartum antibiotic chemoprophylaxis policies for the prevention of group B streptococcal disease worldwide: Systematic review. Clin Infect Dis. 2017;65(2):S143–51.
• Madrid L, Seale AC, Kohli-Lynch M, Edmond KM, Lawn JE, Heath PT, et al. Infant group B streptococcal disease incidence and serotypes worldwide: Systematic review and meta-analyses. Clin Infect Dis. 2017;65(2):S160–72.
• Russell N, Seale AC, O’Driscoll M, O’Sullican C, Bianchi-Jassi F, Gonzalez-Guarin J, et al. Maternal colonization with group B Streptococcus and serotype distribution worldwide: Systematic review and meta-analysis. Clin Infect Dis. 2017;65(2):S100–11.
• Russell N, Seale AC, O’Sullivan C, Le Doare K, Heath PT, Lawn JE, et al. Risk of early-onset neonatal group B Streptococcus disease with maternal colonization worldwide: Systematic review and meta-analysis. Clin Infect Dis. 2017;65(2):S152–59.
• Saha SK, Ahmed ZB, Modak JK, Naziat H, Saha S, Uddin MA, et al. Group B Streptococcus among pregnant women and newborns in Mirzapur, Bangladesh: Colonization, vertical transmission, and serotype distribution. J Clin Microbiol. 2017;55(8):2406–12.
• Seale AC, Bianchi-Jassir F, Russell N, Kohli-Lynch M, Tann CJ, Hall J, et al. Estimates of the burden of group B streptococcal disease worldwide for pregnant women, stillbirths and children. Clin Infect Dis. 2017;65(2):S200–19.
• Seale AC, Blencowe H, Bianchi-Jassir F, Embleton N, Bassat Q, Ordi J, et al. Stillbirth with group B Streptococcus disease worldwide: Systematic review and meta-analysis. Clin Infect Dis. 2017;65(2):S125–32.
• Tann SJ, Martinello K, Sadoo S, Lawn JE, Seale AC, Vega-Poblete M, et al. Neonatal encephalopathy with group B Streptococcus disease worldwide: Systematic review, investigator group datasets, and meta-analysis. Clin Infect Dis. 2017;65(2):S173–89.
• Verani J, Spina N, Lynfield R, et al. Early-onset group B streptococcal disease in the United States: potential for further reduction. Obstet Gynecol. 2014;123(4):828–37.
• Schrag SJ, Verani JR. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: Experience in the United States and implications for a potential group B streptococcal vaccine. Vaccine. 2013;31(Suppl 4):D20–6.
• Edmond KM, Kortsalioudaki C, Scott S, et al. Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet. 2012;379(9815):547–56.
• Verani JR, Schrag SJ. Group B streptococcal disease in infants: Progress in prevention and continued challenges. Clin Perinatol. 2010;37(2):375–92.

 Top of Page